We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+5.97%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$948M
AUM Growth
+$50.5M
Cap. Flow
+$1.62M
Cap. Flow %
0.17%
Top 10 Hldgs %
32.08%
Holding
1,407
New
74
Increased
399
Reduced
348
Closed
95

Sector Composition

Rank Sector Weight
1 Technology 4.2%
2 Healthcare 2.73%
3 Financials 2.33%
4 Industrials 1.91%
5 Consumer Discretionary 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
1226
DELISTED
Blueprint Medicines
BPMC
$570 ﹤0.01%
6
W icon
1227
Wayfair
W
$15.2B
$544 ﹤0.01%
8
LAR
1228
Lithium Argentina AG
LAR
$1.06B
$539 ﹤0.01%
100
SHLS icon
1229
Shoals Technologies Group
SHLS
$1.59B
$537 ﹤0.01%
48
TJX icon
1230
TJX Companies
TJX
$174B
$534 ﹤0.01%
5
BBD icon
1231
Banco Bradesco
BBD
$37.9B
$532 ﹤0.01%
186
HSIC icon
1232
Henry Schein
HSIC
$10.2B
$529 ﹤0.01%
7
FND icon
1233
Floor & Decor
FND
$6.52B
$519 ﹤0.01%
+4
New +$454
GNRC icon
1234
Generac Holdings
GNRC
$12.9B
$505 ﹤0.01%
4
WVVI icon
1235
Willamette Valley Vineyards
WVVI
$13.4M
$501 ﹤0.01%
100
PWP icon
1236
Perella Weinberg Partners
PWP
$1.27B
$494 ﹤0.01%
+35
New +$440
DCO icon
1237
Ducommun
DCO
$2.92B
$462 ﹤0.01%
9
LBRDK icon
1238
Liberty Broadband Class C
LBRDK
$5.12B
$458 ﹤0.01%
8
NVT icon
1239
nVent Electric
NVT
$26.4B
$453 ﹤0.01%
6
-5
-45% -$321
DXC icon
1240
DXC Technology
DXC
$1.75B
$446 ﹤0.01%
21
COCO icon
1241
Vita Coco
COCO
$3.8B
$440 ﹤0.01%
18
CROX icon
1242
Crocs
CROX
$6.71B
$432 ﹤0.01%
3
-2
-40% -$228
GMED icon
1243
Globus Medical
GMED
$11B
$430 ﹤0.01%
8
BCRX icon
1244
BioCryst Pharmaceuticals
BCRX
$2.26B
$426 ﹤0.01%
84
+32
+62% +$180
AGIO icon
1245
Agios Pharmaceuticals
AGIO
$1.89B
$409 ﹤0.01%
+14
New +$375
TLT icon
1246
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
$398 ﹤0.01%
4
-66
-94% -$6.24K
XYL icon
1247
Xylem
XYL
$28.4B
$388 ﹤0.01%
3
TXT icon
1248
Textron
TXT
$15.4B
$384 ﹤0.01%
4
PHR icon
1249
Phreesia
PHR
$702M
$359 ﹤0.01%
15
PTEN icon
1250
Patterson-UTI
PTEN
$3.82B
$358 ﹤0.01%
30

Similar funds

Arax Advisory Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Arax Advisory Partners held 1,407 positions worth $948M, up 5.6% from $898M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Arax Advisory Partners's Q1 2024 filing shows 74 new, 399 increased, 348 reduced and 95 closed positions. Its largest new stake was First Trust Active Factor Large Cap Growth ETF: 58,350 shares worth $1.6M. The largest sale was Vanguard Dividend Appreciation ETF, an estimated $1.63M.

By sector, the portfolio is most concentrated in Technology at 4.2% of assets, down from 4.3% a quarter earlier, followed by Healthcare and Financials.

  • Arax Advisory Partners's largest Q1 2024 buy was First Trust Active Factor Large Cap Growth ETF: 58,350 shares worth $1.6M.
  • Arax Advisory Partners added most to Vanguard Morningstar Small-Cap Growth ETF in Q1 2024, an estimated $1.86M increase.
  • Arax Advisory Partners's biggest Q1 2024 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $1.63M.
  • Arax Advisory Partners fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q1 2024, selling an estimated $735K.
  • Arax Advisory Partners's ten largest holdings make up 32% of its $948M portfolio in Q1 2024.
  • Arax Advisory Partners opened 74 new positions and closed 95 in Q1 2024.
  • Arax Advisory Partners's portfolio value rose 5.6% quarter-over-quarter to $948M.

Based on Arax Advisory Partners's 13F filing for Q1 2024, filed 14 May 2024.